Organogenesis offers products across all FDA classifications.
1 report, 1 independent
Updated Aug 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Organogenesis offers products across all FDA classifications.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Organogenesis (United States)
company in Canton, United States
Nothing else this week.
Related events
- FDA and state authorities are investigating product manufacturers in Utah.
- FDA and Pfizer are seeking regulatory approval for their products.
- Arise is seeking FDA approval for a drug as of October 7, 2026.
- FDA approval enables commercial availability for a product associated with Indianapolis.
- A facility located in St. George is operating under the standards set by the U.S. Food and Drug Administration (FDA) for supplement manufacturing.
Coverage
Newest first; wire copies grouped- GlobeNewswireOrganogenesis Holdings Inc. Reports Second Quarter 2025 Financial Results CANTON, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine